← All trials
NCT05527899
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 3, 2022
- Primary completion
- Jun 30, 2024
- Completion date
- Oct 30, 2024
- First posted
- Sep 6, 2022
- Last posted
- Sep 13, 2022
- Enrollment
- 105
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Tufts UniversityLead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.